New Study Finds More Than 30% Of Patients Use Cannabis For C...| MENAFN.COM

Monday, 06 February 2023 06:07 GMT

New Study Finds More Than 30% Of Patients Use Cannabis For Chronic Pain


(MENAFN- Investor Brand Network)

With more than 30 states allowing some form of cannabis, millions of Americans now have access to the drug in either medical or recreational markets. Over the past decade, research has shown that cannabis has
potential as a treatment for conditions such as chronic pain
without the side effects typically seen in pharmaceuticals. As a result, dozens of states have launched medical markets that allow patients with qualifying medical conditions to purchase and use legal cannabis for medical purposes.

A recent study from the University of Michigan has revealed that...

read more>>

NOTE TO INVESTORS:
The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company's newsroom at

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via
investorwire
to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with
bmw prime . As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text“Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California

415.949.5050 Office

BioMedWire is part of the
investorbrandnetwork .

MENAFN25012023000224011066ID1105476897


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.